Ross Levine: Focus on the critical questions

Ross Levine is a physician-scientist at Memorial Sloan Kettering Cancer Center in New York, where his laboratory studies the genetic basis of myeloid malignancies. Work from Ross’ laboratory has shown how mutations in the JAK–STAT pathway and epigenetic regulators play a role in myeloproliferative n...

Descripción completa

Detalles Bibliográficos
Autor principal: Houston, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2019
Materias:
News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719419/
https://www.ncbi.nlm.nih.gov/pubmed/31439638
http://dx.doi.org/10.1084/jem.20191484
_version_ 1783447930086096896
author Houston, Stephanie
author_facet Houston, Stephanie
author_sort Houston, Stephanie
collection PubMed
description Ross Levine is a physician-scientist at Memorial Sloan Kettering Cancer Center in New York, where his laboratory studies the genetic basis of myeloid malignancies. Work from Ross’ laboratory has shown how mutations in the JAK–STAT pathway and epigenetic regulators play a role in myeloproliferative neoplasms, and JAK inhibitors are now successfully used to treat myeloproliferative neoplasms. We spoke to Ross about his journey in science so far.
format Online
Article
Text
id pubmed-6719419
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-67194192020-03-02 Ross Levine: Focus on the critical questions Houston, Stephanie J Exp Med News Ross Levine is a physician-scientist at Memorial Sloan Kettering Cancer Center in New York, where his laboratory studies the genetic basis of myeloid malignancies. Work from Ross’ laboratory has shown how mutations in the JAK–STAT pathway and epigenetic regulators play a role in myeloproliferative neoplasms, and JAK inhibitors are now successfully used to treat myeloproliferative neoplasms. We spoke to Ross about his journey in science so far. Rockefeller University Press 2019-09-02 2019-08-22 /pmc/articles/PMC6719419/ /pubmed/31439638 http://dx.doi.org/10.1084/jem.20191484 Text en © 2019 Houston http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle News
Houston, Stephanie
Ross Levine: Focus on the critical questions
title Ross Levine: Focus on the critical questions
title_full Ross Levine: Focus on the critical questions
title_fullStr Ross Levine: Focus on the critical questions
title_full_unstemmed Ross Levine: Focus on the critical questions
title_short Ross Levine: Focus on the critical questions
title_sort ross levine: focus on the critical questions
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719419/
https://www.ncbi.nlm.nih.gov/pubmed/31439638
http://dx.doi.org/10.1084/jem.20191484
work_keys_str_mv AT houstonstephanie rosslevinefocusonthecriticalquestions

Ejemplares similares